Krista  Davis net worth and biography

Krista Davis Biography and Net Worth

Senior Vice President and Chief Human Resources Officer of ANI Pharmaceuticals

Ms. Davis joined ANI in September 2022 and brings over 20 years of executive leadership experience in human resources, talent management, and organizational development. Prior to joining ANI, Ms. Davis served as a global Head of People & Organization (“P&O”) for the Novartis Technical Operations Division, where she led P&O for the Global Cell & Gene platforms. She also sat on the Global P&O divisional leadership team, the Cell & Gene leadership team, and on the US P&O board. Prior to Novartis, Ms. Davis was Global Director, Leadership and Talent Management at A.T. Kearny. She also served previously as VP, Head of HR for North America at Reckitt Benckiser, and in a variety of leadership roles at Catalent Pharma Solutions, Biovail Pharmaceuticals, and Dun & Bradstreet. Ms. Davis earned a B.A. from McGill University and an M.A. in Educational Technology from Concordia University.

What is Krista Davis' net worth?

The estimated net worth of Krista Davis is at least $3.99 million as of March 7th, 2025. Ms. Davis owns 66,525 shares of ANI Pharmaceuticals stock worth more than $3,990,835 as of May 19th. This net worth estimate does not reflect any other assets that Ms. Davis may own. Learn More about Krista Davis' net worth.

How old is Krista Davis?

Ms. Davis is currently 50 years old. There are 8 older executives and no younger executives at ANI Pharmaceuticals. The oldest executive at ANI Pharmaceuticals is Mr. James G. Marken, Senior Vice President of Operations, who is 61 years old. Learn More on Krista Davis' age.

How do I contact Krista Davis?

The corporate mailing address for Ms. Davis and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at [email protected]. Learn More on Krista Davis' contact information.

Has Krista Davis been buying or selling shares of ANI Pharmaceuticals?

Krista Davis has not been actively trading shares of ANI Pharmaceuticals over the course of the past ninety days. Most recently, Krista Davis sold 1,000 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $60.86, for a transaction totalling $60,860.00. Following the completion of the sale, the senior vice president now directly owns 66,525 shares of the company's stock, valued at $4,048,711.50. Learn More on Krista Davis' trading history.

Who are ANI Pharmaceuticals' active insiders?

ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Stephen Carey (Senior Vice President, Finance and Chief Financial Officer), Meredith Cook (Senior Vice President, General Counsel and Corporate Secretary), Krista Davis (Senior Vice President and Chief Human Resources Officer), Chad Gassert (Senior Vice President, Corporate Development and Strategy), Ori Gutwerg (Senior Vice President, Generics), Thomas Haughey (Director), Nikhil Lalwani (Pres), Nikhil Lalwani (President and Chief Executive Officer), James Marken (Senior Vice President, Operations and Product Development), Christopher Mutz (Insider), Antonio Pera (Director), Muthusamy Shanmugam (Head of R&D and COO of NJ Operations), Muthusamy Shanmugam (Head of R&D and COO), Renee Tannenbaum (Director), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.

Are insiders buying or selling shares of ANI Pharmaceuticals?

During the last year, insiders at the specialty pharmaceutical company sold shares 25 times. They sold a total of 159,809 shares worth more than $9,777,989.53. The most recent insider tranaction occured on May, 15th when SVP Ori Gutwerg sold 881 shares worth more than $52,921.67. Insiders at ANI Pharmaceuticals own 11.1% of the company. Learn More about insider trades at ANI Pharmaceuticals.

Information on this page was last updated on 5/15/2025.

Krista Davis Insider Trading History at ANI Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/7/2025Sell1,000$60.86$60,860.0066,525View SEC Filing Icon  
2/21/2025Sell1,000$60.20$60,200.0068,624View SEC Filing Icon  
12/11/2024Sell1,000$60.00$60,000.0049,059View SEC Filing Icon  
11/15/2023Sell2,622$53.81$141,089.8232,587View SEC Filing Icon  
See Full Table

Krista Davis Buying and Selling Activity at ANI Pharmaceuticals

This chart shows Krista Davis's buying and selling at ANI Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals logo
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Read More

Today's Range

Now: $60.16
Low: $58.94
High: $60.20

50 Day Range

MA: $66.91
Low: $59.53
High: $72.95

2 Week Range

Now: $60.16
Low: $52.50
High: $77.00

Volume

268,194 shs

Average Volume

298,783 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.56